Search Results - "Huber, Irit"

Refine Results
  1. 1

    Tissue Engineering of Vascularized Cardiac Muscle From Human Embryonic Stem Cells by Caspi, Oren, Lesman, Ayelet, Basevitch, Yaara, Gepstein, Amira, Arbel, Gil, Habib, Irit Huber Manhal, Gepstein, Lior, Levenberg, Shulamit

    Published in Circulation research (02-02-2007)
    “…Transplantation of a tissue-engineered heart muscle represents a novel experimental therapeutic paradigm for myocardial diseases. However, this strategy has…”
    Get full text
    Journal Article
  2. 2

    Cardiomyocyte Differentiation of Human Induced Pluripotent Stem Cells by ZWI, Limor, CASPI, Oren, ARBEL, Gil, HUBER, Irit, GEPSTEIN, Amira, PARK, In-Hyun, GEPSTEIN, Lior

    Published in Circulation (New York, N.Y.) (13-10-2009)
    “…The ability to derive human induced pluripotent stem (hiPS) cell lines by reprogramming of adult fibroblasts with a set of transcription factors offers unique…”
    Get full text
    Journal Article
  3. 3
  4. 4
  5. 5

    Calcium handling in human induced pluripotent stem cell derived cardiomyocytes by Itzhaki, Ilanit, Rapoport, Sophia, Huber, Irit, Mizrahi, Itzhak, Zwi-Dantsis, Limor, Arbel, Gil, Schiller, Jackie, Gepstein, Lior

    Published in PloS one (01-04-2011)
    “…The ability to establish human induced pluripotent stem cells (hiPSCs) by reprogramming of adult fibroblasts and to coax their differentiation into…”
    Get full text
    Journal Article
  6. 6

    Monitoring Human-Induced Pluripotent Stem Cell-Derived Cardiomyocytes with Genetically Encoded Calcium and Voltage Fluorescent Reporters by Shinnawi, Rami, Huber, Irit, Maizels, Leonid, Shaheen, Naim, Gepstein, Amira, Arbel, Gil, Tijsen, Anke J., Gepstein, Lior

    Published in Stem cell reports (13-10-2015)
    “…The advent of the human-induced pluripotent stem cell (hiPSC) technology has transformed biomedical research, providing new tools for human disease modeling,…”
    Get full text
    Journal Article
  7. 7

    Identification and selection of cardiomyocytes during human embryonic stem cell differentiation by Huber, Irit, Itzhaki, Ilanit, Caspi, Oren, Arbel, Gil, Tzukerman, Maty, Gepstein, Amira, Habib, Manhal, Yankelson, Lior, Kehat, Izhak, Gepstein, Lior

    Published in The FASEB journal (01-08-2007)
    “…Human embryonic stem cells (hESC) are pluripotent lines that can differentiate in vitro into cell derivatives of all three germ layers, including…”
    Get full text
    Journal Article
  8. 8

    Electromechanical integration of cardiomyocytes derived from human embryonic stem cells by Gepstein, Lior, Kehat, Izhak, Khimovich, Leonid, Caspi, Oren, Gepstein, Amira, Shofti, Rona, Arbel, Gil, Huber, Irit, Satin, Jonathan, Itskovitz-Eldor, Joseph

    Published in Nature biotechnology (01-10-2004)
    “…Cell therapy is emerging as a promising strategy for myocardial repair. This approach is hampered, however, by the lack of sources for human cardiac tissue and…”
    Get full text
    Journal Article
  9. 9

    Derivation and cardiomyocyte differentiation of induced pluripotent stem cells from heart failure patients by Zwi-Dantsis, Limor, Huber, Irit, Habib, Manhal, Winterstern, Aaron, Gepstein, Amira, Arbel, Gil, Gepstein, Lior

    Published in European heart journal (01-06-2013)
    “…Myocardial cell replacement therapies are hampered by a paucity of sources for human cardiomyocytes and by the expected immune rejection of allogeneic cell…”
    Get full text
    Journal Article
  10. 10

    Human Induced Pluripotent Stem Cell-Derived Cardiac Cell Sheets Expressing Genetically Encoded Voltage Indicator for Pharmacological and Arrhythmia Studies by Shaheen, Naim, Shiti, Assad, Huber, Irit, Shinnawi, Rami, Arbel, Gil, Gepstein, Amira, Setter, Noga, Goldfracht, Idit, Gruber, Amit, Chorna, Snizhanna V., Gepstein, Lior

    Published in Stem cell reports (05-06-2018)
    “…Fulfilling the potential of human induced pluripotent stem cell (hiPSC)-derived cardiomyocytes for studying conduction and arrhythmogenesis requires…”
    Get full text
    Journal Article
  11. 11

    Patient-Specific Drug Screening Using a Human Induced Pluripotent Stem Cell Model of Catecholaminergic Polymorphic Ventricular Tachycardia Type 2 by Maizels, Leonid, Huber, Irit, Arbel, Gil, Tijsen, Anke J, Gepstein, Amira, Khoury, Asaad, Gepstein, Lior

    “…BACKGROUND—Catecholaminergic polymorphic ventricular tachycardia type 2 (CPVT2) results from autosomal recessive CASQ2 mutations, causing abnormal Ca-handling…”
    Get full text
    Journal Article
  12. 12

    In vitro electrophysiological drug testing using human embryonic stem cell derived cardiomyocytes by Caspi, Oren, Itzhaki, Ilanit, Kehat, Izhak, Gepstein, Amira, Arbel, Gil, Huber, Irit, Satin, Jonathan, Gepstein, Lior

    Published in Stem cells and development (01-01-2009)
    “…Pro-arrhythmia (development of cardiac arrhythmias as a pharmacological side effect) has become the single most common cause of the withdrawal or restrictions…”
    Get more information
    Journal Article
  13. 13

    Optogenetic Control of Human Induced Pluripotent Stem Cell-Derived Cardiac Tissue Models by Gruber, Amit, Edri, Oded, Glatstein, Shany, Goldfracht, Idit, Huber, Irit, Arbel, Gil, Gepstein, Amira, Chorna, Snizhanna, Gepstein, Lior

    Published in Journal of the American Heart Association (15-02-2022)
    “…Background Optogenetics, using light-sensitive proteins, emerged as a unique experimental paradigm to modulate cardiac excitability. We aimed to develop…”
    Get full text
    Journal Article
  14. 14
  15. 15

    In Vivo Assessment of the Electrophysiological Integration and Arrhythmogenic Risk of Myocardial Cell Transplantation Strategies by Gepstein, Lior, Ding, Chunhua, Rehemedula, Dolkun, Wilson, Emily E., Yankelson, Lior, Caspi, Oren, Gepstein, Amira, Huber, Irit, Olgin, Jeffery E.

    Published in Stem cells (Dayton, Ohio) (01-12-2010)
    “…Cell replacement strategies are promising interventions aiming to improve myocardial performance. Yet, the electrophysiological impact of these approaches has…”
    Get full text
    Journal Article
  16. 16

    Optogenetic modulation of cardiac action potential properties may prevent arrhythmogenesis in short and long QT syndromes by Gruber, Amit, Edri, Oded, Huber, Irit, Arbel, Gil, Gepstein, Amira, Shiti, Assad, Shaheen, Naim, Chorna, Snizhana, Landesberg, Michal, Gepstein, Lior

    Published in JCI insight (08-06-2021)
    “…Abnormal action potential (AP) properties, as occurs in long or short QT syndromes (LQTS and SQTS, respectively), can cause life-threatening arrhythmias…”
    Get full text
    Journal Article
  17. 17

    Mechanism of spontaneous excitability in human embryonic stem cell derived cardiomyocytes by Satin, Jonathan, Kehat, Izhak, Caspi, Oren, Huber, Irit, Arbel, Gil, Itzhaki, Ilanit, Magyar, Janos, Schroder, Elizabeth A., Perlman, Ido, Gepstein, Lior

    Published in The Journal of physiology (01-09-2004)
    “…Human embryonic stem cell-derived cardiomyocytes (hES-CMs) are thought to recapitulate the embryonic development of heart cells. Given the exciting potential…”
    Get full text
    Journal Article
  18. 18

    Characterization of the mechanism by which a nonsense variant in RYR2 leads to disordered calcium handling by Hopton, Claire, Tijsen, Anke J., Maizels, Leonid, Arbel, Gil, Gepstein, Amira, Bates, Nicola, Brown, Benjamin, Huber, Irit, Kimber, Susan J., Newman, William G., Venetucci, Luigi, Gepstein, Lior

    Published in Physiological reports (01-04-2022)
    “…Heterozygous missense variants of the cardiac ryanodine receptor gene (RYR2) cause catecholaminergic polymorphic ventricular tachycardia (CPVT). These missense…”
    Get full text
    Journal Article
  19. 19

    Reprogramming of telomeric regions during the generation of human induced pluripotent stem cells and subsequent differentiation into fibroblast-like derivatives by Yehezkel, Shiran, Rebibo-Sabbah, Annie, Segev, Yardena, Tzukerman, Maty, Shaked, Rony, Huber, Irit, Gepstein, Lior, Skorecki, Karl, Selig, Sara

    Published in Epigenetics (01-01-2011)
    “…Human induced pluripotent stem (hiPS) cells provide therapeutic promises, as well as a potent in vitro model for studying biological processes which take place…”
    Get full text
    Journal Article
  20. 20

    The ARF1 GTPase-Activating Protein: Zinc Finger Motif and Golgi Complex Localization by Cukierman, Edna, Huber, Irit, Rotman, Miriam, Cassel, Dan

    “…Hydrolysis of guanosine triphosphate (GTP) by the small guanosine triphosphatase (GTPase) adenosine diphosphate ribosylation factor-1. (ARF1) depends on a…”
    Get full text
    Journal Article